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Introduction/DNP Final Project Overview 
The population of focus is the University of Kentucky heart and lung transplant patients.  
Patients eligible for heart transplants are typically in end-stage heart failure caused by viral 
infections, damage to heart valves or muscle, coronary heart disease or hereditary conditions.   
Lung transplant patients also have end-stage disease (ESLD) caused by conditions such as 
idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, cystic fibrosis, alpha-1 
antitrypsin deficiency, or pulmonary hypertension.  Research over the years supports the need for 
continuous psychiatric monitoring for these patients with end-stage diseases due to the higher 
incidence of anxiety and depression within this population.  According to Campbell and Etringer 
(1999), a review of the literature suggests depression is a cause and a consequence of non-
adherence in transplant patients.  Non-adherence with medical treatment is the third leading 
cause of rejection of organs after simple allograft rejection and systemic infection (Campbell & 
Etringer, 1999, p. 59S).  
Transplant Background 
The United Network for Organ Sharing (UNOS) is a non-profit, scientific and educational 
organization that administers the only Organ Procurement and Transplantation Network (OPTN) 
in the United States.  UNOS (2015) is involved in many aspects of the organ transplant and 
donation process including the following:   
• Managing the national transplant waiting list, matching donors to recipients 24 hours a 
day, 365 days a year; 
• Maintaining the database that contains all organ transplant data for every transplant event 
that occurs in the U.S.; 
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• Bringing together members to develop policies that make the best use of the limited 
supply of organs and give all patients a fair chance at receiving the organ they need, 
regardless of age, sex, ethnicity, religion, lifestyle or financial/social status; 
• Monitoring every organ match to ensure organ allocation policies are followed; 
• Providing assistance to patients, family members and friends; 
• Educating transplant professionals about their important role in the donation and 
transplant processes; 
• And educating the public about the importance of organ donation. 
The following are examples of criteria set by UNOS for transplant candidates:  age, ability of the 
patient to recover, ABO type, height and weight, life support status, listing status and time on the 
waiting list.  Each organ type has individual criteria.  For example, with heart transplantation, 
candidate recipients are given one of four status levels (1A – the highest level, 1B, 2, and 7).
 
  A 
matching candidate of Status 1A within the donor region, of matching ABO type, and within 500 
miles will be given the highest priority, with multiple matches being ranked by time on the 
waiting list.  Each of those criteria will be progressively relaxed until a match is found 
The OPTN Ethics Committee recognizes the difficulty applying broad measures of 
adherence to accepting transplant candidates since empirical measures are limited, and medical 
professionals often approach these issues subjectively. In social and medical venues, debate 
continues to focus on alcoholism, drug abuse, smoking, eating disorders and other behaviors as 
diseases or character flaws.  Such behaviors are associated with disease processes in many 
adults.  The Ethics Committee has historically supported the conclusion that past behavior that 
results in organ failure should not be considered a sole basis for excluding transplant candidates.  
However, transplantation should be considered very cautiously for individuals who have 
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demonstrated serious, consistent, and documented non-adherence in current or previous 
treatment. 
Adherence Background 
Adherence and compliance are synonyms defined as the extent to which patients follow 
the instructions they are given for prescribed treatments (Haynes, McDonald, Garg, & Montague, 
2002, p. 1).     The terms are used interchangeably; however, the term adherence is intended to be 
non-judgmental, a statement of fact rather than to blame of the patient, prescriber or treatment 
(Haynes et al., 2002, p. 1).  Causes of non-adherence include the following:  problems with the 
regimen such as adverse effects of medications, poor instructions, poor provider-patient 
relationships, patients’ disagreement with the need for treatment and inability to pay for 
treatment.   
In 2010, the costs of health care in the U.S. exceeded $2.7 trillion and accounted for 
17.9% of the gross domestic product (Iuga & McGuire, 2014, p. 35).  According to Iuga & 
McGuire (2014), the U.S. health care system wastes 20% to 30% of dollars spent.   Between 
$100 and $300 billion of avoidable health care cost have been attributed to non-adherence in the 
U.S. annually, representing 3% to 10% of total U.S. health care cost (Iuga & McGuire, 2014, p. 
37). 
 Many reasons exist for non-adherence to medical regimens, including problems with the 
regimen (such as adverse effects); poor instructions; poor provider-patient relationship; patients’ 
disagreement with the need for treatment or inability to pay for it (Haynes et al., 2002, p. 2).  The 
most common regimens assessed for adherence include the following: medications, screening, 
exercise, health behavior, appointment and diet (DiMatteo, 2004). Health behaviors, 
appointment-keeping, and diet yield lower adherence averages; each is significantly lower than 
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its comparison with other regimens (DiMatteo, 2004, p. 204).  Methods of measuring adherence 
include the following:  pill count, physical test, medical record/chart, self-report, collateral report 
and electronic monitoring (DiMatteo, 2004).   The quantitative review by DiMatteo (2004) 
determined self-reporting, collateral reporting, and medical records yield lower average 
adherence scores compared to pill counting, physical tests, and electronic monitoring.   
The National Center for Health and Statistics (2012) reports the U.S. spent $259 billion 
on prescription drugs.  According to Iuga & McGuire (2014), medication non-adherence is 
widespread and varied by disease, patient characteristics, and insurance coverage, with non-
adherence rates ranging from 25% to 50%.  Patient non-adherence to prescribed medications is 
associated with poor therapeutic outcomes, the progression of the disease, and an estimated 
burden of billions per year in avoidable direct health care costs (Iuga & McGuire, 2014, p. 35). 
Missed appointments are associated with an increased risk of hospitalization and 
mortality (Nwabuo, Dy, Weeks, & Young, 2014, p. 1).  According to a quantitative review by 
Dr. DiMatteo (2004), appointment non-adherence is approximately 34.1%.  Past research 
indicates patients who miss appointments tend to by younger and of lower socioeconomic status 
(Lacy, Paulman, Reuter, & Lovejoy, 2004, p. 541).  According to Lacy et al., (2004), these 
patients typically have a history of failed appointments, government-provided health benefits, 
and psychosocial problems.  Lacy et al., (2004) also determined longer waiting times have been 
shown to be related to lower satisfaction, which, leads to less reliable appointment keeping. 
The final DNP project is a compilation of my work over the last five years.  I have selected these 
articles because they represent my abilities to understand and apply the DNP Essentials.  All of 
the papers within the final DNP project address different aspects of the transplant population. 
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Abstract 
Patient wait times inversely correlate with patient satisfaction.  The University of Kentucky 
Transplant Clinic conducted a patient satisfaction survey, which indicated that inefficient clinic 
processes are prolonging patient wait times.  Transplant Clinic patients experience several 
processes before rooming, which significantly contributes to their total wait time.  The 
Transplant Clinic established a goal of having at least 50% of patients roomed within 30 minutes 
of their scheduled appointment time.  Transplant Clinic audits revealed that the largest number of 
patients not reaching this goal were liver transplant patients. The audit also indicated that the 
period that contributed greatest to the delay in rooming was the wait time encountered after 
phlebotomy.  Patients were asked to arrive 60 minutes before their appointment time as part of a 
new scheduling protocol.   Results indicated that 75% of appointments that utilized this protocol 
met the goal of being roomed within 30 minutes of appointment time.  By decreasing wait time 
and improving clinic flow, it is predicted that patient satisfaction will improve.  
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Introduction 
 Patient flow logistics are an important component of a clinic’s process.  For effective 
scheduling, outpatient ambulatory clinic systems need to match demand with capacity, so that 
resources are better utilized and patient waiting times reduced (Dhar, Michel, & Kanna, 2011; 
Edward et al., 2008; Racine & Davidson, 2002).  Patient waiting time and waiting room 
congestion are quality indicators that are related to the efficiency of ambulatory care systems and 
patient satisfaction (Camacho, Anderson, Safrit, Jones, & Hoffmann, 2006).  Medical institutions 
are increasingly sensitive to the impact of patient satisfaction in a competitive medical 
marketplace.  Patient satisfaction depends not only on the surgical outcome, but also on the 
entire process from initial scheduling of the appointment to the time before the date of operation, 
to the postoperative visit (Gibler, Nyswonger, Engel, Grannan, & Welling, 2011). 
 
Background 
 Previous studies have identified an indirect relationship between the length of time that a 
patient waits in an office and that patient’s level of satisfaction with their medical provider (Dhar 
et al., 2011; Camacho et al., 2006; Gibler et al., 2011; Bleustein et al., 2014; Guglielmo, 
Plesnick, Greenspan, & Sharif, 2013; Harnett, Correll, Hurwitz, Bader, & Hepner, 2010; Huang, 
2013).  Because satisfaction scores are reflections of the quality of care patients feel they have 
received, many facilities have studied how to improve clinic flow to decrease patient wait times 
and improve patient satisfaction (Dhar et al., 2011; Edward et al., 2008; Racine & Davidson, 
2002; Huang, 2013).  The University of Kentucky (UK) Transplant Clinic performed a patient 
satisfaction survey, which identified patient waiting times as having the poorest satisfaction 
score. Based on the findings of previous studies, this long wait time experienced by patients may 
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not only decrease the overall efficiency of clinic processes but can potentially negatively 
influence the patient experience (Dhar et al., 2011; Harnett et al., 2010).  Also, research indicates 
that extended waiting times also affect the patients’ perceived quality of care (Dhar et al., 2011; 
Bleustein et al., 2014).  Therefore, the goal of this project was to utilize the 8-step process to 
improve patient flow through the clinic, the overall quality of care and patient satisfaction.
 Over a 30-day period, from May 30, 2014, through June 30, 2014, the UK Transplant 
Clinic performed an audit on patient flow from check-in to checkout for all patients seen in the 
clinic.  During this audit, 906 patients were tracked through patient check-in, registration, labs, 
vital signs, and rooming.  The focus of this audit was to identify the delays that contributed to 
patient rooming times greater than 30 minutes from the scheduled appointment times.  
The UK Transplant Clinic is divided into the following organ groups: heart and lung, 
kidney and pancreas, and liver.  Of the transplant clinics, the liver clinic was found to have the 
greatest number of patients roomed in greater than 30 minutes from appointment time.  For all 
organ groups, the longest waiting period occurred between the labs station and the vital signs 
station.  Another trend noted was the liver clinic patients were not directed to arrive early for 
their scheduled appointments. 
Methods 
 The initial patient population consisted of patients who received pre-transplant or post-
transplant care at the University of Kentucky Transplant Clinic from June 1, 2014, to June 30th, 
2014.  The Transplant Quality Assurance and Performance Improvement (QAPI) manager, 
Jennifer Watkins, RN, CCTC, de-identified the data, removing protected health information 
before releasing the data to our team of researchers.  Therefore, per Institutional Review Board 
protocols, patient consent was not required for this study.   
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 All UK Transplant Clinic appointments were audited daily as part of the clinic 
performance improvement initiatives.  Data for the month of June, collected in the APM and 
Lobby registration systems, was utilized for this project.  For each of these appointments, the 
following descriptive data were collected: appointment date, organ transplant team, the reason 
for appointment, and patient-provider.  Additionally, numerical data was comprised of the 
recorded times for the following patient checkpoints: appointment time, check-in, beginning and 
completion times of registration, phlebotomy, vital signs collection, time of patient placement in 
the exam room, and patient discharge time.  From the 904 original appointments, all 
appointments that were missing one or more descriptive or numerical data points were excluded, 
leaving 465 patient encounters to be analyzed.  
 Using Microsoft Excel for data analysis, each appointment was evaluated as to whether it 
met the clinic’s goal of patient placement in the exam room within 30 minutes of the 
appointment time.  Overall, 214 patients met this standard, leaving a gap of 251 patients who 
failed to be roomed within 30 minutes.  The organ transplant team further sorted these 251 
appointments by organ group to identify which group had the greatest volume of patients not 
meeting the 30-minute standard.  This organ-based division revealed that ten heart patients, 45 
kidney patients, 91 lung patients, and 105 liver patients did not meet the standard, identifying the 
liver transplant group as the group with the greatest number of patients not meeting the standard 
(See Table 1). 
 For the 105 appointments in the data set, the time elapsed between each checkpoint was 
calculated to identify the specific point in the patient flow which contributed the greatest amount 
to the overall wait time and then averaged to determine the overall delay for each point-of-
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occurrence.  The greatest waiting time was found to be the period between the phlebotomy and 
vital sign collection; on average this time was 44.4 minutes. 
 In early December 2014, our team met with the Transplant Clinic QAPI Manager and the 
Transplant Clinic staff to identify possible countermeasures that would reduce the phlebotomy to 
vital signs waiting time, thereby facilitating the rooming of patients within the 30-minute 
standard.  Creating a new protocol for scheduling appointments to allow time for the phlebotomy 
process would be the most practical and efficient solution.  Data analysis demonstrated the 
kidney transplant team has a greater number of appointments and the largest number of patients 
who meet the 30-minute standard.  The new scheduling protocol for the liver team modeled the 
kidney team’s schedule which requires patients to arrive at the clinic an hour before their 
scheduled appointment time.  Per the new protocol, as liver team patients scheduled new 
appointments, they would be asked to arrive 60 minutes earlier than their appointment time.  
This small cycle of change would allow time for the phlebotomy process and have patients to 
roomed within 30-minutes of their scheduled appointment time.  
In December 2014, a trial of this protocol was conducted.  The QAPI Manager identified 
four liver transplant patients who had multiple appointments scheduled within a 30-day trial 
period.  Front desk clerks were directed to give verbal instructions to these trial patients to arrive 
60 minutes before their scheduled appointment time to allow for completion of labs.  As with the 
initial audit, time point data was collected via APM and Lobby registration systems.  For each 
encounter in which the patient did arrive at least one hour early, data was further analyzed 
manually.  Appointment time to rooming time was calculated and compared to the 30-minute 
standard to assess the effectiveness of the countermeasure.  
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Results 
Of the four Transplant Clinic patients who were asked to arrive 60 minutes before their 
originally scheduled appointment time, two patients refused to comply with new scheduling 
protocol.  The two patients that participated in the new scheduling protocol arrived 60 minutes 
before their scheduled appointment time on two separate occasions for a total of four 
appointments (Table 1). Three out of 4 appointment times met the standard of being roomed 
within 30 minutes of their scheduled appointment times (Figure 1). As a comparison, before 
implementation of the new scheduling protocol, 56 of 161 liver patients (35%) met the standard 
of being roomed within 30 minutes of their appointment time.  
Discussion 
Summary of main findings 
The purpose of this project was to identify and implement a change that would improve 
patient flow through the transplant clinic, reduce patient waiting room time and congestion, and 
improve overall patient satisfaction.  Patient waiting time and waiting room congestion are 
quality indicators related to the efficiency and patient satisfaction of ambulatory care systems 
(Camacho et al., 2006; Bleustein et al., 2014; Harnett et al., 2010; Huang, 2013).  A 
comprehensive audit in June 2014 of the patient flow through the UK Transplant Clinic 
identified the liver team as the group with the largest number of patients with a waiting time 
longer than 30 minutes, and the period between labs and vital signs as the time with the greatest 
average waiting time.  By implementing a scheduling protocol change in December 2014, which 
allotted time for lab collection and processing, participating patients were able to get their blood 
drawn, and results returned from the lab to the clinic before the time that they were scheduled to 
meet with their clinical provider.  When they arrived 60 minutes before appointment time, our 
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sample population met the standard of being roomed within 30 minutes of their scheduled 
appointment time with a 75% success rate, an improvement over the 35% success rate before the 
change.  By decreasing wait time and waiting room congestion, it is expected that patient 
satisfaction will improve. 
Comparison with existing literature 
The initial Transplant Clinic audit successfully identified specific points of delay that 
could be addressed in quality improvement measures to improve patient satisfaction.  The 
process and findings of this audit were congruent with several recent studies on patient flow 
(Dhar et al., 2011; Harnett et al., 2010; Racine & Davidson, 2002).  This project identified 
patient wait times as a measure of patient satisfaction and perceived quality of care, as similar 
studies have demonstrated this to be effective means for improvement (Camacho et al., 2006; 
Bleustein et al., 2014; Harnett et al., 2010).  More specifically, the intervention of having 
patients arrive early for pre-appointment testing was found to reduce waiting time and improve 
overall patient satisfaction by 7-9% in one surgical clinic (Huang, 2013).  The results are 
supported by previous research that demonstrates an inverse correlation between patient wait 
time and satisfaction (Camacho et al., 2006; Gibler et al., 2011; Bleustein et al., 2014; Guglielmo 
et al., 2013; Harnett et al., 2010; Huang, 2013). 
Limitations 
The sample population was very small in comparison to the number of patients the Liver 
team sees on a daily basis.  Several factors limited the sample population: transplant clinic 
patients are chronically ill, they have frequent appointments, and many patients travel several 
hours to receive care at the UK transplant clinic. These patients are familiar with the previous 
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clinic flow, and it is imperative to give them as much notice as possible when making changes to 
reduce the amount of stress they incur.  The nature of the project failed to afford the time to 
phase in changes at a rate comfortable for patients; during this trial, two of the four patients 
asked to arrive early refused.  Although the sample was small, and adherence was inconsistent, 
the positive results complement the current success the kidney team has with their early arrival 
protocol, suggesting that phasing in this change for the liver patients will be successful in 
meeting the goal of reducing wait time and improving patient satisfaction.  
Future recommendations 
It is recommended that the liver team study this small cycle of change on a larger trial 
population--without causing stress to current patients--by phasing in protocol changes as new 
patients get referred to the clinic.  Rather than phrasing the instructions as a request to arrive 
early, the scheduler should inform the patient that the appointment for labs is at “X” time and the 
appointment with the clinician is at “Y” time, scheduling these two events as separate entities 
and prohibiting refusal by the patient.  Performing patient satisfaction surveys and comparing 
results among patients scheduled arrive early for their appointment and patients who do not 
arrive early will provide additional data supporting these changes as a means to achieve greater 
patient satisfaction.  Future quality improvement projects should consider additional ways to 
improve patient satisfaction, which could include streamlining lab processes to reduce time spent 
in the clinic and improving consistency between scheduling protocols of the different organ 
teams within the transplant clinic.  
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Figure 1. Pie chart representing the percentage of patients roomed and not roomed within the 
standard 30 minutes of appointment time after the protocol change. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not Roomed 
Within 30 Minutes 
of Appointment 
Time 
25% 
Roomed Within 30 
Minutes of 
Appointment Time 
75% 
17 
 
Table 1. Breakdown of patients who met and did not meet the standard 30 minute room 
time before and after implementation of new schedule protocol 
 
 Standard  
Met 
Standard  
Not Met  
(Gap) 
Number  
Of 
Patients 
Percentage 
Meeting 
Standard 
Before new 
Scheduling 
Protocol 
56 105 161 35% 
After new 
Scheduling 
Protocol  
3 1 4 75% 
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Abstract 
Background: The purpose of this literature review is to identify scientific evidence supporting 
the need for continuous psychosocial evaluation beginning in the pre-transplant stage and 
continuing through the post-transplant stage for the duration of the patient’s life. 
Methods:  A comprehensive search of the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), COCHRANE Library, Medical Literature Analysis and Retrieval System 
Online (MEDLINE), PUBMED and Center for Medicare and Medicaid approved transplant 
program databases was conducted using the following combinations of keywords and terms: 
Adult Heart Transplant, Adult Lung Transplant, end-stage heart disease, end-stage lung disease, 
anxiety, stress, depression, psychosocial and psychological needs.  Studies were selected if they 
assessed the psychological and the psychosocial needs of adult heart or lung transplant patients.   
Results: Ten journal articles met the inclusion criteria.  The primary level of evidence was 
systematic reviews of cross-sectional and correlational studies with non-independent reference 
standards which is Level IV.  Two of the studies were systematic reviews of cross-sectional 
studies and one expert opinion study.   
Conclusion:  All studies were in agreement that end-stage lung disease, end-stage heart disease, 
and heart and lung transplant patients are susceptible to anxiety, depression, and non-adherence.  
The studies also recommended a multidisciplinary team approach with ongoing psychosocial 
health assessments to improve the quality of life for this population.  Finally, these studies 
recommended a combination of medication and psychoeducational interventions to further 
improve their quality of life for end-stage disease and transplant patients.   
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Introduction 
The purpose of this literature review is to determine if ongoing psychosocial assessments 
improve patient outcomes and quality of life in heart and lung transplant patients.  Patients with 
end-stage heart and lung disease are chronically ill and frequently suffer from psychosocial 
problems.  Patients eligible for heart transplants are typically in end-stage heart failure caused by 
viral infections, damage to heart valves and muscle, coronary heart disease or hereditary 
conditions (National Institutes of Health National Heart Lung and Blood Institute Explore Heart 
Transplant website, 2012).  Lung transplant patients also have end-stage lung disease (ESLD) 
caused by conditions such as idiopathic pulmonary fibrosis, COPD, cystic fibrosis, alpha-1 
antitrypsin deficiency, or pulmonary hypertension (National Institutes of Health National Heart 
Lung and Blood Institute Explore Lung website, 2011).  Research over the years supports the 
need for continuous psychiatric monitoring for these patients with end-stage diseases due to the 
higher incidence of anxiety and depression within this population.  Recommended options for 
treating anxiety and depression include but not limited to the following: counseling, 
pharmacological therapy, and support groups. 
According to Campbell and Etringer (1999), a review of the literature suggests 
depression is a cause and a consequence of non-adherence in transplant patients.  Non-adherence 
with medical treatment is the third leading cause of rejection of organs after simple allograft 
rejection and systemic infection (Campbell & Etringer, 1999, p. 59S).  A comprehensive 
literature review by Fusar-Poli et al. (2007) identifies the following as having a central role in 
causing depressive states in lung transplant recipients: personality disorders, coping strategies, 
stressful life events, physical complications, corticosteroid medications, age, gender, and 
psychosocial support. Fusar-Poli et al. (2007) concluded depression in lung transplant recipients 
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is a risk factor for future non-adherence, poor quality of life, increased the risk of physical 
complications and likely increased morbidity and mortality.   
Methods 
Data Sources 
A comprehensive search of the Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), COCHRANE Library, Medical Literature Analysis and Retrieval System Online 
(MEDLINE), PUBMED and Center for Medicare and Medicaid approved transplant program 
databases was conducted using the following combinations of keywords and terms: Adult Heart 
Transplant, Adult Lung Transplant, anxiety, stress, depression, psychosocial and psychological 
needs.  Studies were selected if they assessed the psychological and psychosocial needs of adult 
heart or lung transplant patients.   
Data Extraction 
The search was limited to articles in the English language, published after January 1999, 
which reported on assessments of and interventions for psychological needs of adult heart and 
lung transplant patients. References in the extracted articles were examined for potentially 
relevant articles. Studies were selected if they assessed the psychological needs of adult heart 
and lung transplant patients pre-operatively and post-transplantation, and end-stage heart and 
lung disease patients.  Exclusion criteria included articles that focused on pediatric transplant 
recipients and other transplanted organs.  A total of sixteen publications were obtained from the 
search of databases.  After assessing titles and abstracts of the retrieved articles, ten publications 
met the inclusion/exclusion criteria.   
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Results 
 From the ten journal articles that met the inclusion/exclusion criteria, 2 are well-designed 
systematic reviews, 7 are descriptive studies, and 1 is expert opinion.  The Center for Evidence-
Based Medicine (CEBM) grades evidence on a scale in which Level I is the strongest evidence 
decreasing to Level V, the weakest evidence (See Table 1).  The CEBM classifies the systematic 
review as Level I evidence (See Table 1).  The seven descriptive studies ranked as Level IV (See 
Table 1).  The Level V evidence is one expert opinion (See Table 1).  The CEBM further 
evaluates the levels on a scale and assigns a grade of recommendation (See Table 2).  The grade 
of recommendations for the articles included the following: grade A (n=2); grade C (n=7); and 
grade D (n=1). 
The systematic review of depression following transplantation or the efficacy and safety 
of therapeutic interventions in lung transplant patients thoroughly identifies causes and 
treatments in this population.  This study identifies serotonin reuptake inhibitors and new 
generation antidepressants as the best therapeutic choices for this group (Fusar-Poli et al., 2007, 
p. 55).  It also makes a point to stress the need for careful monitoring by experts due to the risk 
of drug-drug interactions (Fusar-Poli et al., 2007).  Complementary therapies and psycho-
educational intervention also help recipients to strengthen their coping strategies, offering further 
advantages after transplantation (Fusar-Poli et al., 2007, p. 55).   
The Level IV evidence was primarily descriptive cross-sectional studies.  These articles 
further supported the same conclusions found in the systematic review.  Singer et al. (2001) 
wanted to identify personality styles and psychopathology in patients presenting with end-stage 
lung disease (ESLD) (Singer, Ruchinskas, Riley, Broshek, & Barth, 2001, p. 1246).  This study 
determined separate and distinct personality styles that could affect the quality of life, the need 
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for adjunct treatments, and medical adherence in individuals with ESLD (Singer et al., 2001).   
According to Limbos et al., even though lung transplant recipients have better general, physical, 
and psychological health than their pre-transplant counterparts, both pre- and post-transplant 
patients experience impairment in several psychological functioning.   
Level V evidence included expert opinions.  For example, the American Heart 
Association, the Heart Rhythm Society and American Association of Critical Care Nurses 
endorse the need for patients with implantable cardioverter defibrillators (ICDs) to receive 
education and psychiatric care to cope with the anxiety, stress and post-traumatic stress disorders 
(PTSD) (Dunbar et al., 2012).  ICDs are frequent in end-stage heart disease patients; therefore 
assessment for anxiety, depression, and PTSD is imperative in this population.  Development or 
modification of coping skills in both the patient and those close to the patient would work the 
best to counter depression-driven etiology of non-adherence (Campbell and Etringer, 1999).  
Non-adherence in the transplant population leads to decreased quality of health and a decreased 
quality of life.   
Conclusion 
The levels of evidence were primarily Levels IV and V and a recommendation grade of C and D.  
All studies were in agreement that end-stage lung and heart disease patients and heart and lung 
transplant patients are susceptible to anxiety, depression, and non-adherence.  Evidence-based 
practice recommends a multidisciplinary team approach with continuous psychosocial evaluation 
of transplant patients.  To further improve quality of life, these studies recommended a 
combination of medication and psychoeducational interventions would be beneficial.  This 
literature review demonstrates the importance of ongoing mental health assessments to improve 
the quality of life for end-stage heart and lung disease patients and transplanted patients.   
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Table 1. Level of evidence grading table  
 Level 1 Level 2 Level 3 Level 4 Level 5 
Diagnosis Systematic review 
of cross-sectional 
studies 
Systematic review of 
cross-sectional 
studies with 
consistently applied 
reference standard 
and blinding 
Systematic review of 
nonconsecutive 
studies, or studies 
without consistently 
applied reference 
standards 
Systematic review of 
case-control study, or 
cross-sectional study 
with non-
independent 
reference standard 
Opinion 
Treatments Systematic review of 
randomized trials or 
n-of-1 trial 
Randomized trial or 
(exceptionally) 
observational studies 
with dramatic effect 
Non-randomized 
controlled 
cohort/follow-up 
study 
Systematic review of 
case-control studies, 
historically controlled 
studies 
Opinion 
Outcome  Systematic 
review of inception 
cohort studies 
Inception cohort 
studies 
Cohort or control arm 
of randomized trial 
Systematic review of 
case series 
Opinion 
Adapted from the Centre for Evidence-Based Medicine (CEBM) Level of Evidence March 2009 
 
Table 2. Grades of recommendation 
A Consistent level 1 studies 
B Consistent level 2 or 3 studies or extrapolations from level 1 studies 
C Level 4 studies or extrapolations from level 2 or 3 studies 
D Level 5 evidence or troublingly inconsistent or inconclusive studies of any level 
Consensus Opinion supported by entire Canadian Fibromyalgia Guidelines Committee 
The level may be graded down on the basis of study quality, imprecision, indirectness, because of inconsistency between studies, or 
because the absolute effect size is very small; Level may be graded up if there is a large or very large effect size.  
 
Howick, J., Chalmers, I., Glasziou, P., Greenhalgh, T., Heneghan, C., Liberati, A., Moschetti, I., Phillips, B., Thornton, H., Goddard, 
O., Hodgkinson, M., The Oxford 2011 Table of Evidence. Oxford Centre for Evidence-Based Medicine. 
http://www.cebm.net/index.aspx?o=5653  
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Table 3. Summary of articles 
Population-specific Studies 
Author/Year/Journal/Title/ 
Reference Information 
Type of 
Literature/ 
Design 
Sampl
e Size 
Purpose of Article/ 
Findings/ 
Implications 
CEBM 
Evidence 
Level 
CEBM 
Evidence 
Grade 
Singer, H. K., Ruchinskas, R. A., 
Riley, K. C., Broshek, D. K., 
& Barth, J. T. (2001). The 
psychological impact of end-
stage lung disease. CHEST, 
120(4), 1246-1252. Retrieved 
from 
http://uky.worldcat.org.ezprox
y.uky.edu/oclc/4590203890 
Cross-
sectional 
survey 
243 The purpose of this article is to elucidate personality 
styles and the presence of psychopathology of in a 
clinical sample of patients with ESLD presenting for a 
possible lung transplant. 
The majority of patients evidenced mild somatic and 
depressive symptoms.  Approximately one fourth of 
the sample exhibited marked anxiety and mood 
disturbances.  A small cluster also evidenced features 
consistent with an antisocial personality disorder.  
Separate and distinct personality styles that could 
affect the quality of life, the need for adjunct 
treatments and medical adherence emerged from this 
sample of individuals with ESLD.   
IV C 
Dunbar, S. B., Dougherty, C. M., 
Sears, S. F., Carroll, D. L., 
Goldstein, N. E., Mark, D. B., 
... Zeigler, V. L. (2012). 
Educational and 
psychological interventions to 
improve outcomes for 
recipients of implantable 
cardioverter defibrillators and 
their families. Circulation, 
126, 2146-2172. 
http://dx.doi.org/10.1161/CIR.
0b013e31825d59fd 
Systematic 
Review  
>5000 The purpose of the review is to describe the 
psychological and quality-of-life outcomes after 
receipt of an ICD and describe related factors, such as 
patient characteristics; (2) describe the concerns and 
educational/informational needs of ICD patients and 
their family members; (3) outline the evidence that 
supports interventions for improving educational and 
psychological outcomes for ICD patients; (4) provide 
recommendations for clinical approaches for 
improving patient outcomes; and (5) identify priorities 
for future research in this area. The ultimate goal of 
this statement is to improve the precision of 
identification and care of psychosocial distress in ICD 
patients to maximize the derived benefit of the ICD.  
I A 
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Problem-specific Studies 
Campbell, B., & Etringer, G. (1999). 
Post-transplant quality of life 
issues: depression-related 
noncompliance in cardiac 
transplant patients 
[Supplemental material 4A]. 
Transplantation Proceedings, 
31, 59S-60S. 
http://dx.doi.org/10.1016/S0041-
1345(99)00130-X 
 
Descriptive, 
Retrospectiv
e 
185 The purpose is to determine to what degree unrecognized or 
untreated depression causes noncompliant behavior and 
subsequent allograft rejection in cardiac transplant recipients. 
Our survey established that the depression-driven etiology of 
non-adherence would best be countered by development or 
modification of coping skills in both the patient and those 
close 
to the patient. 
More detailed studies of depression and non-adherence 
including intervention strategies are needed 
to improve understanding and the impact these strategies 
could have on post-transplant outcomes. 
IV C 
Miller, M.D., M. (2002). Depression 
after cardiac transplant treated 
with interpersonal psychotherapy 
and paroxetine. Depression after 
cardiac transplant treated with 
interpersonal psychotherapy and 
paroxetine, 56(4), 555-61.  
Descriptive 
case study 
1  Discuss the treatment of a 67-year old man with no prior 
history of psychiatry illness diagnosed with major depression 
following heart transplantation.  Psychotherapy and 
paroxetine were successful in treating depression in this heart 
transplant patient 
These efforts may apply to other heart transplant patients 
V D 
Stavem, K., Bjortuft, O., Lund, M. B., 
Kongshaug, K., Geiran, O., & 
Boe, J. (2000). Health-related 
quality of life in lung transplant 
candidates and recipients. 
Respiration, 67(2), 159-165. 
 
The study is 
a cross-
sectional 
postal 
survey 
46 The objective is to compare the health-related quality of life 
of lung transplant recipients with lung transplant candidates, 
using lung-specific and general instruments, and to assess the 
reliability and validity of these questionnaires.  Patients 
surviving lung transplantations can expect a considerable 
improvement in most dimensions of health-related quality of 
life.  Lung transplant patients can expect to have 
improvements in health-related quality of life 
IV C 
Intervention-specific Studies 
Bright, M. J., Craven, J. L., & Kelly, 
P. J. (1990). Assessment and 
management of psychosocial 
stress in lung transplant 
candidates. Health & Social 
Descriptive, 
Prospective 
40  Describe the psychosocial aspects of lung transplant and the 
role of the social worker been described as it applies in this 
clinical context.  This assessment alerts staff to the individual 
strengths and vulnerabilities of the candidates, facilitates the 
team in working with individual coping styles, allows 
IV C 
29 
 
Work, 15(2), 125-32. 
http://dx.doi.org/10.1093/hsw/15
.2.125 
 
implementation of prophylactic interventions, and ensures 
that program resources adequately meet the demands of 
patients who are accepted to the waiting list.  These efforts 
have proven to be effective and well received with a 
minimum of complications. 
Evon, D. M., Burker, E. J., Galanko, 
J. A., Dedert, E., & Egan, T. M. 
(2010). Depressive symptoms 
and mortality in lung transplant. 
Clinical Transplantation, 24(5), 
E201-E206. 
http://dx.doi.org/10.1111/j.1399-
0012.2010.01236.x 
 
Descriptive, 
prospective, 
longitudinal 
study 
200 To determine whether depressive symptoms predicted 
survival before and after lung transplantation. Pre-transplant 
depressive symptoms were associated with mortality among 
lung transplant candidates in an unadjusted model and a 
model fit with demographics and forced expiratory volume in 
one second.  Depressive symptoms do not exert an 
independent effect when forced expiratory vital capacity is 
added. Depressive symptoms do not predict mortality after 
transplant.  Future studies need to determine whether pre-
transplant psychosocial characteristics confer a greater risk 
for poorer transplant outcomes. 
IV C 
Fusar-Poli, P., Lazzaretti, M., Ceruti, 
M., Hobson, R., Petrouska, K., 
Cortesi, M.,...Politi, P. (2007). 
Depression after lung 
transplantation: causes and 
treatment. Lung, 185(2), 55-65. 
http://dx.doi.org/10.1007/s00408
-006-0093-1 
 
Systematic 
review 
N/A The purpose is to explore the causes of depression following 
transplantation or the efficacy and safety of therapeutic 
interventions in this patient group.  Personality disorders, 
coping strategies, stressful life events, physical 
complications, corticosteroid medications, age, gender, and 
psychosocial support all play a central role in causing 
depressive states in lung 
transplant recipients. Serotonin reuptake inhibitors (SSRIs) 
and new-generation antidepressants (mirtazapine) represent 
the best therapeutic choices for this group of patients.  
Complementary therapies and psychoeducational intervention 
also help recipients to strengthen their coping strategies, 
offering further advantages after transplantation.  This review 
aimed to promote a debate between clinicians and non-
psychiatric health care workers to organize efficient health 
services able to screen patients for depressive symptoms and 
to refer them for appropriate treatment. 
I A 
Grandi, S., Fabbir, S., Tossani, E., 
Mangelli, L., Branzi, A., & 
Mangelli, C. (2001). 
Descriptive 129 The aim of this study was to compare these new criteria 
(Diagnostic Criteria for Psychosomatic Research, DCPR) 
with DSM-IV in a population where a high prevalence of 
IV C 
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Psychological evaluation after 
cardiac transplantation: the 
integration of different criteria. 
Psychotherapy and 
Psychosomatics, 70(), 176-183. 
http://dx.doi.org/10.1159/000056
250 
psychological problems are expected (heart-transplanted 
patients).  At least one DCPR diagnosis was found in 85 
(66%) patients, whereas at least one DSM diagnosis was 
present in 23 (18%) patients.  The joint use of DSM and 
DCPR criteria was found to improve the identification of 
psychological factors which could result in a worsening of 
quality of life in heart-transplanted patients. 
Limbos, M. M., Joyce, D. P., Chan, 
C. K., & Kesten, S. (2000). 
Psychological functioning and 
quality of life in lung transplant 
candidates and recipients*. 
CHEST, 118(2), 408.  
Descriptive 
correlational 
study 
109 The purpose of the study is to examine the psychological 
functioning and quality of life (QOL) of lung transplant 
candidates and recipients.  Although lung transplant 
recipients have better general, physical and psychological 
health than their pre-transplant counterparts, the present 
research suggests that both groups experience impairment in 
several areas of psychological functioning. Additional 
research should be aimed at recognizing, intervening, and 
improving patients’ psychological and emotional well-being 
IV C 
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Introduction 
Background and Significance 
Transplant psychosocial listing criteria are not well standardized in the tools and 
techniques utilized by medical providers (Maldonado et al., 2012).  The United Network for 
Organ Sharing (UNOS) has established minimal medical listing criteria for each organ system 
(Maldonado et al., 2012).  The Organ Procurement Transplant Network (OPTN) bylaws (2015) 
state “all transplant programs shall identify appropriately trained individuals who are designated 
members of the transplant team and have primary responsibility for coordinating the 
psychosocial needs of transplant candidates, recipients, living donors and families.”  The use of 
assessment tools, such as the Stanford Integrated Psychosocial Assessment for Transplant 
(SIPAT), not only assists clinicians in eliminating the emotional factor from the decision-making 
process but also in presenting the facts during the selection process (Maldonado et al., 2012, p. 
129).  The function of psychosocial consultants should not be to make a determination regarding 
the patient’s worthiness as a candidate, but to assist the transplant selection committee in making 
the best clinical decision based on currently available data (Maldonado, 2009).  
Review of Literature and Conceptual Perspective 
A qualitative analysis literature review, from 1970 thru 1990 by Dew et al. (2000), 
concluded the following regarding psychosocial assessments: 1.) They differ in content and 
application to candidate selection; 2.) Psychosocial status pre-transplant does not consistently 
affect medical outcomes post-transplant; 3.) Patients’ psychosocial status typically improves 
with transplant, although difficulties are prevalent in psychological adjustment and adherence to 
medical regimens; 4.) Psychiatric history can predict psychological outcomes after transplant but 
does not consistently predict adherence; 5.) Social supports and coping strategies strengthen 
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psychosocial outcomes;  and 6.) Post-transplant psychosocial outcomes may predict physical 
morbidity and mortality.  Studies have demonstrated an association with the transplant 
psychiatrist’s global rating of risk for post-transplant psychosocial problems that affect 
management and post-transplant non-adherence and the number of rejection episodes (Shapiro, 
Williams, Gelman, Foray, & Wukich, 1997).  According to Campbell and Etringer (1999), a 
review of the literature suggests depression is a cause and a consequence of non-adherence with 
anti-rejection medications in transplant patients.  Non-adherence with medical treatment is the 
third leading cause of rejection of organs after simple allograft rejection and systemic infection 
(Campbell & Etringer, 1999, p. 59S).  Depression in transplant recipients is a risk factor for 
future non-adherence, poor quality of life, physical complications, morbidity, and mortality 
(Fusar-Poli et al., 2007).   
There are three other standardized tools available for psychosocial assessment for 
transplant patients.  The PACT uses a 5-point scale for ten items and the rater’s overall 
impression (Olbrisch, Levenson, & Hamer, 1989).  Allowing for rater’s overall impression 
defeats the attempt at objectivity (Presberg, Levenson, Olbrisch, & Best, 1995).  The 
Psychosocial Levels System (PLS) assesses patients on three gradations of intensity: Level 1 
(mild/minimal); Level 2 (moderate); and Level 3 (severe), taking into account past psychiatric 
history, quality of family and social support, prior coping history, coping with disease and 
treatment, quality of affect, proneness to anticipatory problems, and mental status (Futterman, 
Wellisch, Bond, & Carr, 1991, p. 177).  Beyond the original paper nothing else was published 
about the PLS most likely because The Transplant Evaluation Rating Scale (TERS) is a revision 
of the PLS and it seems to have replaced it (Maldonado et al., 2012).  TERS classifies patients’ 
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level of adjustment in 10 aspects of psychosocial functioning that are thought to be important in 
adjusting to transplantation (Twillman, Manetto, Wellisch, & Wolcott, 1993, p. 144).   
The SIPAT tool (See Appendix A) was presented to the UK transplant physicians in 
January 2013 by Dr. Maldonado from Stanford University. The SIPAT tool standardizes the 
psychosocial assessment evaluation process so all transplant candidates undergo the same 
rigorous psychosocial scrutiny helping identify areas of strength that can be built upon, and areas 
of weakness needing assistance or further consultation and treatment (Maldonado et al., 2012, p. 
129).  The SIPAT tool uses 18 identified risk factors divided into four domains.  Based on the 
assessment of these factors, the SIPAT provides an overall risk severity score for psychosocial 
variables significant in predicting post-transplant behavior, psychosocial support viability and 
effectiveness, treatment adherence, substance abuse, recidivism and mental health (Maldonado et 
al., 2012, p. 126).  Currently, the University of Kentucky (UK) Cardiothoracic Transplant Clinic 
uses the UK Transplant Center Social Work and Family Risk Assessment Tool (See Appendix 
B) developed by the social workers in the transplant clinic to assess the patient’s psychosocial 
needs and identify areas which may lead to poor outcomes if the patient is transplanted.  This 
tool uses a qualitative design to the identified risk factors. 
Objectives 
The aim is to determine if the SIPAT tool produces highly predictive transplant 
psychosocial outcomes compared to the current tool, the UK Transplant Center Social Work and 
Family Risk Assessment tool, in the University of Kentucky (UK) cardiothoracic post-transplant 
patient population.   
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Methods and Procedures 
Study Population 
The UK Cardiothoracic Transplant Clinic post-transplant population is comprised of 
chronically ill male and female patients with either end-stage heart or lung disease who have 
received a heart or lung transplant.  To retrospectively apply the SIPAT tool at the period of 
transplant selection, a convenience sample of 100 electronic medical records (EMR) of 
transplanted cardiothoracic patients during January 1, 2012, through September 15, 2015, was 
selected.  After the SIPAT tool had been applied to 100 EMRs, the chart was reviewed for the 
following negative outcomes:  lack of adherence, lack of stability of psychosocial support 
system, recidivism of substances of abuse, the development/relapse of psychiatric problems or 
graft failure.  Positive outcomes are defined as the absence of these complications.      
Adherence was assessed by patient’s ability to keep scheduled appointments, refill anti-
rejection medication on time and take only medications approved by the transplant team.  The 
stable support system was identified by the presence of a support person post-transplant and the 
support person being actively involved in patient care by ensuring the patient had appropriate 
access to medical care at all times.  Appropriate living space and the environment was assessed 
by appropriately connected utilities.  Recidivism of substances of abuse was determined by the 
review of the chart for relapse of tobacco or illicit drugs.  Development or relapse of psychiatric 
problems was assessed by the addition of psychiatric medication prescribed to the patient post-
transplant that wasn’t previously prescribed.  Graft rejection was determined by biopsy per the 
transplant protocol.  One point was assigned to each outcome if the patient had a complication or 
was non-adherent; therefore a patient could be 0 with no negative outcomes or 5 with a negative 
outcome in each category.   
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Data Analysis 
Subgroup analysis of all results was conducted to determine if there was significant 
variability in the results by demographic factors (e.g. gender, ethnicity, organ implanted, age at 
the time of transplant, and distance from patient’s home to the transplant clinic).  Simple linear 
regression was conducted to compare the SIPAT score with the number of complications 
encountered by each patient.  All statistical analysis was carried out using Microsoft Excel 
(Microsoft Office Home and Student 2010, Version 14.0.7166.5000). 
Results 
A total of 105 charts were reviewed, with five charts removed because the patients did 
not follow up postoperatively at the UK Cardiothoracic Transplant Clinic and outcomes were 
unable to be assessed (See Table 1).  The group was comprised of (n=52) heart transplant 
patients, (n=2) heart and lung transplant patients and (n=46) lung transplant patients.  The self-
identified ethnicity of the group consisted of the following: 90% Caucasian; 7% African-
American/Black; 1% Hispanic; 1% Asian; and 1% Biracial.  In eighty percent of the charts 
reviewed the patient was living, and 20% were deceased.  The mean age at the time of transplant 
was 49.4 (SD=15.7) years.  The distance the patient lived from the UK Transplant Clinic was a 
mean of 108.65 (SD=146.1) miles.   
The mean SIPAT score was 15.9 (SD=13.3) with an average number 1.97 (SD=1.37) 
negative outcomes.  The regression analysis for this study indicates a significant moderate 
positive correlation (r = 0.52) between the SIPAT scores and the number of negative outcomes 
patients will experience post-transplant (See Figure 1.)  In the simple linear regression analysis, 
SIPAT score was a significant predictor of the number of negative outcomes (b=.054; p< .0001). 
The SIPAT score explained 27% of the variability in the number of negative outcomes in post-
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transplant patients.  Furthermore, based on the listing criteria set forth by the SIPAT tool, 37% of 
the patients had absolute contraindications to listing the patients for a transplant.  Based on their 
psychosocial assessments these patients would not have been transplanted until the 
contraindications had been addressed adequately. 
Discussion 
The SIPAT had only been studied in Stanford’s transplant population.  This study 
validates the tool within the UK Cardiothoracic Transplant population because it shows a 
correlation between the number of post-transplant negative outcomes and the SIPAT score.  The 
SIPAT tool is quantitative, and this provides the committee with a visual of predicted post-
transplant negative outcomes.  Both tools provide an opportunity to develop interventions to 
prevent negative outcomes. 
Current recommendations set forth by UNOS and OPTN include comprehensive medical 
evaluation and a psychosocial assessment (Maldonado et al., 2012).  The data collected by the 
UK Transplant Center Social Work and Family Risk Assessment Tool is the same data gathered 
in the SIPAT tool.  However, the UK Transplant Center Social Work and Family Risk 
Assessment Tool do not assign a numerical value to the data, and it does not have clear 
guidelines for listing criteria.  The data in this study confirms the SIPAT scores were highly 
predictive of the transplant patients’ psychosocial outcomes.  These findings are consistent with 
the original study performed by Stanford (Maldonado et al., 2012).   
Limitations of the Project 
The SIPAT tool is designed for prospective assessment of patients; however, the time 
constraints of the project prevented this type of study.  Retrospectively using the tool allowed 
assessment of its usefulness in this population without having to wait extended periods of time 
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while patients on the waiting list are transplanted and eventual outcomes presented.  The original 
study had four reviewers, and they were able to evaluate inter-rater reliability compared to this 
study with one reviewer of the charts.  The Stanford study included heart, lung and liver 
transplant patients.  The instrument was limited to historical data contained within the patient’s 
chart rather than having the opportunity to perform the exam on a live patient.  Stanford was 
already utilizing a quantitative tool, so there was a comparison of scores between the tools. UK’s 
tool is qualitative, and a direct comparison cannot be made with the SIPAT tool. Finally, it cannot 
be determined if patient outcomes would be affected by the application of strengths or 
interventions for weaknesses.  
Conclusion 
The application of a standardized psychosocial assessment tool that utilizes a weighted 
value to each identified risk factors for transplant outcomes demonstrated its strength to identify 
patients who are at risk for negative outcomes after the transplant.  The SIPAT scores were 
found to be highly predictive of the psychosocial outcomes in the UK cardiothoracic transplant 
population.  Utilization of a standardized tool will allow for the development of interventions 
directed at improving the patient’s candidacy (Maldonado et al., 2012, p. 130).   Further study is 
recommended utilizing additional people to review charts to determine inter-rater reliability 
along with applying the tool in a prospective method to determine if patient outcomes improve 
with interventions. 
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Table 1.  Demographic characteristics of study participants 
Organs n=100(%) 
Heart 52 (52%) 
Heart and Lung 2 (2%) 
Lung 46 (46%) 
  
Gender  
Male 67 (67%) 
Female 43 (43%) 
  
Ethnicity  
African-American/Black 7 (7%) 
Asian 1 (1%) 
Biracial 1 (1%) 
Caucasian 90 (90%) 
Hispanic 1 (1%) 
  
Mortality  
Living 80 (80%) 
Deceased 20 (20%) 
  
Average age of patient 49.4 years 
  
Average distance from the UK Transplant 
Clinic 
108.65 miles 
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Figure 1. Regression analysis of SIPAT scores vs. # of negative outcomes 
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DNP Final Project Report Conclusions 
According to UNOS (2015), approximately 120,152 people need a lifesaving organ 
transplant. An active transplant candidate is eligible to be considered for organ offers at any 
given point in time.  Of the approximate 120,000 people, 77,353 people are active waiting list 
candidates.  From January through June 2016, 16,445 organ transplants have been performed 
with 7,764 total donors (United Network for Organ Sharing, 2015).  As medical advances 
continue, people will continue living longer with comorbidities and the transplant candidate 
waiting list will continue to grow.   Therefore, it is obvious the availability of organs is low, and 
the demand is high.   
Research has demonstrated the importance of continued assessment of psychosocial 
needs to minimize non-adherence in chronically ill patients.  Standardizing psychosocial 
assessment tool criteria will help to quickly identify areas for potentially negative outcomes in 
end-stage organ disease patients and transplant patients.  Qualitative tools collect verbal data 
which is analyzed and has rater bias; however, a quantitative tool will minimize bias by 
presenting the data objectively.   
The transplant committee is tasked with the goal to identify the most medically and 
psychosocially suitable candidates due to the lack of availability of organs.  Providing the 
committee with a psychosocial assessment tool which was developed on evidence-based 
practices will ensure the best candidates are selected. 
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